Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Jae Seok | - |
dc.contributor.author | Gopalappa, Ramu | - |
dc.contributor.author | Kim, Se Hoon | - |
dc.contributor.author | Ramakrishna, Suresh | - |
dc.contributor.author | Lee, Minji | - |
dc.contributor.author | Kim, Woo-il | - |
dc.contributor.author | Kim, Junho | - |
dc.contributor.author | Park, Sang Min | - |
dc.contributor.author | Lee, Junehawk | - |
dc.contributor.author | Oh, Jung-Hwa | - |
dc.contributor.author | Kim, Heung Dong | - |
dc.contributor.author | Park, Chang-Hwan | - |
dc.contributor.author | Lee, Joon Soo | - |
dc.contributor.author | Kim, Sangwoo | - |
dc.contributor.author | Kim, Dong Seok | - |
dc.contributor.author | Han, Jung Mm | - |
dc.contributor.author | Kang, Hoon-Chul | - |
dc.contributor.author | Kim, Hyongbum (Henry) | - |
dc.contributor.author | Lee, Jeong Ho | - |
dc.date.accessioned | 2022-07-14T12:36:03Z | - |
dc.date.available | 2022-07-14T12:36:03Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2017-03 | - |
dc.identifier.issn | 0002-9297 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/152782 | - |
dc.description.abstract | Focal cortical dysplasia (FCD) is a major cause of the sporadic form of intractable focal epilepsies that require surgical treatment. It has recently been reported that brain somatic mutations in MTOR account for 15%-25% of FCD type II (FCDII), characterized by cortical dyslamination and dysmorphic neurons. However, the genetic etiologies of FCDII-affected individuals who lack the MTOR mutation remain unclear. Here, we performed deep hybrid capture and amplicon sequencing (read depth of 100 x-20,012 x) of five important mTOR pathway genes-PIK3CA, PIK3R2, AKT3, TSC1, and TSC2-by using paired brain and saliva samples from 40 FCDII individuals negative for MTOR mutations. We found that 5 of 40 individuals (12.5%) had brain somatic mutations in TSC1 (c.64C>T [p.Arg22Trp] and c.610C>T [p.Arg204Cys]) and TSC2 (c.4639G>A [p.Va11547I1e]), and these results were reproducible on two different sequencing platforms. All identified mutations induced hyperactivation of the mTOR pathway by disrupting the formation or function of the TSC1TSC2 complex. Furthermore, in utero CRISPR-Cas9-mediated genome editing of Tsc1 or Tsc2 induced the development of spontaneous behavioral seizures, as well as cytomegalic neurons and cortical dyslamination. These results show that brain somatic mutations in TSC1 and TSC2 cause FCD and that in utero application of the CRISPR-Cas9 system is useful for generating neurodevelopmental disease models of somatic mutations in the brain. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | CELL PRESS | - |
dc.title | Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ramakrishna, Suresh | - |
dc.contributor.affiliatedAuthor | Park, Chang-Hwan | - |
dc.identifier.doi | 10.1016/j.ajhg.2017.01.030 | - |
dc.identifier.scopusid | 2-s2.0-85012906963 | - |
dc.identifier.wosid | 000395851900012 | - |
dc.identifier.bibliographicCitation | AMERICAN JOURNAL OF HUMAN GENETICS, v.100, no.3, pp.454 - 472 | - |
dc.relation.isPartOf | AMERICAN JOURNAL OF HUMAN GENETICS | - |
dc.citation.title | AMERICAN JOURNAL OF HUMAN GENETICS | - |
dc.citation.volume | 100 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 454 | - |
dc.citation.endPage | 472 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Genetics & Heredity | - |
dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
dc.subject.keywordPlus | TUBEROUS SCLEROSIS COMPLEX | - |
dc.subject.keywordPlus | MAMMALIAN TARGET | - |
dc.subject.keywordPlus | CELL-GROWTH | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | MTOR | - |
dc.subject.keywordPlus | EPILEPSY | - |
dc.subject.keywordPlus | BRAIN | - |
dc.subject.keywordPlus | MALFORMATIONS | - |
dc.subject.keywordPlus | PATHWAY | - |
dc.subject.keywordPlus | CRISPR-CAS9 | - |
dc.subject.keywordAuthor | brain mosaicism | - |
dc.subject.keywordAuthor | brain somatic mutation | - |
dc.subject.keywordAuthor | CRISPR-Cas9 genome editing | - |
dc.subject.keywordAuthor | focal cortical dysplasia | - |
dc.subject.keywordAuthor | intractable epilepsy | - |
dc.subject.keywordAuthor | TSC1 | - |
dc.subject.keywordAuthor | TSC2 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0002929717300319?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.